For bumped kinase inhibitors targeting Cryptosporidium, P-glycoprotein reduces the therapeutic enterocyte exposure, and this is associated with reduced in vivo efficacy in a mouse model of cryptosporidiosis. The gene discussed is ABCB1; the disease is cryptosporidiosis.